IRIS Accounts Production v25.2.0.378 09243189 director 1.4.24 31.3.25 31.3.25 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092431892024-03-31092431892025-03-31092431892024-04-012025-03-31092431892023-03-31092431892023-04-012024-03-31092431892024-03-3109243189ns15:EnglandWales2024-04-012025-03-3109243189ns14:PoundSterling2024-04-012025-03-3109243189ns10:Director12024-04-012025-03-3109243189ns10:PrivateLimitedCompanyLtd2024-04-012025-03-3109243189ns10:SmallEntities2024-04-012025-03-3109243189ns10:AuditExempt-NoAccountantsReport2024-04-012025-03-3109243189ns10:SmallCompaniesRegimeForDirectorsReport2024-04-012025-03-3109243189ns10:SmallCompaniesRegimeForAccounts2024-04-012025-03-3109243189ns10:FullAccounts2024-04-012025-03-3109243189ns10:OrdinaryShareClass12024-04-012025-03-3109243189ns10:OrdinaryShareClass22024-04-012025-03-3109243189ns10:OrdinaryShareClass32024-04-012025-03-3109243189ns10:OrdinaryShareClass42024-04-012025-03-3109243189ns5:CurrentFinancialInstruments2025-03-3109243189ns5:CurrentFinancialInstruments2024-03-3109243189ns5:ShareCapital2025-03-3109243189ns5:ShareCapital2024-03-3109243189ns5:RetainedEarningsAccumulatedLosses2025-03-3109243189ns5:RetainedEarningsAccumulatedLosses2024-03-3109243189ns10:RegisteredOffice2024-04-012025-03-3109243189ns5:ComputerEquipment2024-04-012025-03-3109243189ns5:ComputerEquipment2024-03-3109243189ns5:ComputerEquipment2025-03-3109243189ns5:ComputerEquipment2024-03-3109243189ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3109243189ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-3109243189ns5:AcceleratedTaxDepreciationDeferredTax2025-03-3109243189ns5:AcceleratedTaxDepreciationDeferredTax2024-03-3109243189ns5:DeferredTaxation2024-03-3109243189ns5:DeferredTaxation2024-04-012025-03-3109243189ns5:DeferredTaxation2025-03-3109243189ns10:OrdinaryShareClass12025-03-3109243189ns10:OrdinaryShareClass22025-03-3109243189ns10:OrdinaryShareClass32025-03-3109243189ns10:OrdinaryShareClass42025-03-31092431891ns10:Director12024-03-31092431891ns10:Director12023-03-31092431891ns10:Director12024-04-012025-03-31092431891ns10:Director12023-04-012024-03-31092431891ns10:Director12025-03-31092431891ns10:Director12024-03-31
REGISTERED NUMBER: 09243189 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED

31 MARCH 2025

FOR

DOMAREX UK LTD

DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025










Page

Balance Sheet 1

Notes to the Financial Statements 3


DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

BALANCE SHEET
31 MARCH 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 5 - 269

CURRENT ASSETS
Debtors 6 16,941 77,340
Cash at bank 106,008 92,745
122,949 170,085
CREDITORS
Amounts falling due within one year 7 33,050 32,446
NET CURRENT ASSETS 89,899 137,639
TOTAL ASSETS LESS CURRENT
LIABILITIES

89,899

137,908

PROVISIONS FOR LIABILITIES 8 - 67
NET ASSETS 89,899 137,841

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 89,799 137,741
SHAREHOLDERS' FUNDS 89,899 137,841

DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

BALANCE SHEET - continued
31 MARCH 2025


The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss account has not been delivered.

The financial statements were approved by the director and authorised for issue on 1 September 2025 and were signed by:





Mr H C Robinson - Director


DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025


1. STATUTORY INFORMATION

Domarex UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 09243189

Registered office: 53 Gildredge Road
Eastbourne
East Sussex
BN21 4SF

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Equipment - 33% on cost

All fixed assets are initially recorded at cost.

DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


3. ACCOUNTING POLICIES - continued

Financial instruments
The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities, like trade and other accounts receivable and payable, loans from banks and other third parties and loans to / from related parties.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at the present value of the future cash flows and subsequently measured at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade payables or receivables, are measured, initially and subsequently, at the undiscounted transaction price less any impairment.

If the arrangements of a short term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate, the financial asset or liability is measured, initially, at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of the estimated cash flows discounted at the asset's original effective rate.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the reporting date.

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the entity after deducting all of its financial liabilities.

Where the contractual obligations of financial instruments (including share capital) are equivalent to a similar debt instrument, those financial instruments are classed as financial liabilities. Financial liabilities are presented as such in the balance sheet and measured as detailed above.

Where the contractual terms of share capital do not have any terms meeting the definition of a financial liability then this is classed as an equity instrument. Dividends and distributions relating to equity instruments are debited direct to equity.

Finance costs are charged to the profit and loss over the term of the financial asset / liability using the effective interest method so that the amount charged is at a constant rate on the carrying amount.


DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


3. ACCOUNTING POLICIES - continued
Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2024 - 1 ) .

5. TANGIBLE FIXED ASSETS
Equipment
£   
COST
At 1 April 2024
and 31 March 2025 791
DEPRECIATION
At 1 April 2024 522
Charge for year 269
At 31 March 2025 791
NET BOOK VALUE
At 31 March 2025 -
At 31 March 2024 269

DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Directors' current accounts 16,735 77,148
VAT 206 192
16,941 77,340

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Corporation tax 29,950 31,041
PAYE and social security 1,819 -
Accruals and deferred income 1,281 1,405
33,050 32,446

8. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax
Accelerated capital allowances - 67

Deferred
tax
£   
Balance at 1 April 2024 67
Provided during year (67 )
Balance at 31 March 2025 -

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
97 Ordinary A £1 97 97
1 Ordinary B £1 1 1
1 Ordinary C £1 1 1
1 Ordinary D £1 1 1
100 100

DOMAREX UK LTD (REGISTERED NUMBER: 09243189)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2025


10. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

2025 2024
£    £   
Mr H C Robinson
Balance outstanding at start of year 77,148 79,193
Amounts advanced 38,804 77,955
Amounts repaid (99,217 ) (80,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 16,735 77,148

Beneficial loan interest has been charged at HMRC's official rate of 2.25% (2024: 2.25%) amounting to £1,044 (2024: £1,739).